Skip to search.
 TSX Down 0.38% TSX Ventures Up 0.42%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
9.76 Down 0.20(2.01%) 10:31AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:9.96
Open:10.00
Bid:9.57 x 500
Ask:9.61 x 700
1y Target Est:18.09
Beta:4.23
Next Earnings Date: 8-May-15BCRX Earnings announcement
Day's Range:9.50 - 10.09
52wk Range:7.29 - 14.62
Volume:147,566
Avg Vol (3m):926,784
Market Cap:707.19M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 2.01%707.19M
GSKDown 0.06%112.63B
RHHBYDown 1.80%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):52.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.04
Quarterly EPS Est (Mar-15) :-0.25
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback